OncoCyte

OncoCyte Corporation is a biotechnology company that specializes in the development and commercialization of proprietary laboratory-developed tests for cancer detection, particularly through non-invasive methods. The company offers several diagnostic tests, including DetermaRx, which is designed for early-stage adenocarcinoma of the lung, and DetermaIO, a gene expression-based test. Additionally, OncoCyte is developing DetermaDx, a blood-based test for lung cancer detection. The company aims to provide actionable insights to physicians and patients to enhance diagnosis and treatment while improving patient outcomes and reducing healthcare costs. OncoCyte also collaborates with Guardian Research Network to streamline patient recruitment and regulatory processes for pharmaceutical clients. Established in 2009, OncoCyte is headquartered in Irvine, California.